Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biocryst Pharma Inc
(NQ:
BCRX
)
7.920
+0.170 (+2.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biocryst Pharma Inc
< Previous
1
2
3
4
5
6
7
Next >
BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth
May 03, 2023
Via
Benzinga
Recap: BioCryst Pharma Q1 Earnings
May 03, 2023
Via
Benzinga
Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today?
April 18, 2023
BioCryst Pharmaceuticals (BCRX) stock is slipping on Tuesday after the biotech company announced new funding to pay down debts.
Via
InvestorPlace
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday
April 18, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Shares of BioCryst Pharmaceuticals Jumped Today
February 22, 2023
A day after the stock plummeted, it bounced back.
Via
The Motley Fool
Analyst Sees Attractive Entry Opportunity After BioCryst's Pipeline Setback
February 22, 2023
Via
Benzinga
Why BioCryst Pharmaceuticals Stock Is Sinking Today
February 21, 2023
Investors didn't like the drugmaker's Q4 update.
Via
The Motley Fool
Biocryst Pharmaceuticals's Earnings Outlook
February 20, 2023
Via
Benzinga
BioCryst Shelves Development Of Rare Blood Disorder Candidate
December 15, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
Via
Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 21, 2023
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
Via
Benzinga
Expert Ratings for BioCryst Pharmaceuticals
November 02, 2022
Analysts have provided the following ratings for BioCryst Pharmaceuticals (NASDAQ:BCRX) within the last quarter:
Via
Benzinga
BioCryst Pharmaceuticals (BCRX) Q3 2022 Earnings Call Transcript
November 01, 2022
BCRX earnings call for the period ending September 30, 2022.
Via
The Motley Fool
BioCryst Pharmaceuticals (BCRX) Q4 2022 Earnings Call Transcript
February 21, 2023
BCRX earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Why BioCryst Pharmaceuticals Stock Is Sliding Today
February 21, 2023
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Tuesday after the company reported worse-than-expected earnings results<
Via
Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Via
Benzinga
BioCryst Pharmaceuticals Stock Is Tumbling: What's Going On?
January 09, 2023
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Monday after the company announced preliminary fourth-quarter and full
Via
Benzinga
TSLA Stock Price Prediction: What to Know as Analysts Slash Tesla Price Targets
December 15, 2022
Tesla (TSLA) stock is in the news as price predictions continue to be a hot topic among traders after Elon Musk's Twitter purchase.
Via
InvestorPlace
Why Is Getaround (GETR) Stock Up 6% Today?
December 15, 2022
Getaround (GETR) stock is on the move Thursday with heavy trading despite a lack of recent news concerning the car-sharing service.
Via
InvestorPlace
BCRX Stock Sinks as BioCryst Discontinues Drug Development
December 15, 2022
BioCryst Pharmaceuticals (BCRX) stock is falling on Thursday after revealing it's no longer developing BCX9930 for competitive reasons.
Via
InvestorPlace
Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 15, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday
December 05, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
BioCryst Pharmaceuticals Stock Sees RS Rating Rise To 84
November 11, 2022
The Relative Strength (RS) Rating for BioCryst Pharmaceuticals stock climbed into a new percentile Friday, with a rise from 64 to 84.
Via
Investor's Business Daily
4 Analysts Have This to Say About BioCryst Pharmaceuticals
November 02, 2022
Within the last quarter, BioCryst Pharmaceuticals (NASDAQ:BCRX) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
Upgrades
Via
Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
November 02, 2022
Gainers
Via
Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
November 01, 2022
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
Via
Benzinga
Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday
November 01, 2022
U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
What's Going On With BioCryst Pharmaceuticals Stock Today?
November 01, 2022
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Tuesday after the company reported third-quarter financial results.
Via
Benzinga
BioCryst Pharmaceuticals: Q3 Earnings Insights
November 01, 2022
BioCryst Pharmaceuticals (NASDAQ:BCRX) reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.